
Antibodies Assay Kits Biology Cells Brd4 Antibody Muc2 Antibody NATtrol Nedd4 Antibody Nox1 Antibody Panel Particles PCR Pcr Kits Peptides Vector & Virus Vi Alpha Vitronectin Antibody Western Blot Zebrafish Antibodies
Glycolysis-related gene expression profiling serves as a novel prognosis risk predictor for human hepatocellular carcinoma
Metabolic sample reconstruction is a vital think about tumor development. Metabolism of tumor cells is characterised by irregular enhance in anaerobic glycolysis, no matter excessive oxygen focus, leading to a major accumulation of power from glucose sources.
These adjustments promotes speedy cell proliferation and tumor development, which is additional referenced a course of generally known as the Warburg impact. The present examine reconstructed the metabolic sample in development of most cancers to determine genetic adjustments particular in most cancers cells. A complete of 12 widespread kinds of stable tumors have been included within the present examine.
Gene set enrichment evaluation (GSEA) was carried out to research 9 glycolysis-related gene units, that are implicated within the glycolysis course of. Univariate and multivariate analyses have been used to determine unbiased prognostic variables for building of a nomogram based mostly on clinicopathological traits and a glycolysis-related gene prognostic index (GRGPI).
The prognostic mannequin based mostly on glycolysis genes confirmed excessive space beneath the curve (AUC) in LIHC (Liver hepatocellular carcinoma). The findings of the present examine confirmed that eight genes (AURKA, CDK1, CENPA, DEPDC1, HMMR, KIF20A, PFKFB4, STMN1) have been correlated with total survival (OS) and recurrence-free survival (RFS).
Additional evaluation confirmed that the prediction mannequin precisely distinguished between high- and low-risk most cancers sufferers amongst sufferers in several clusters in LIHC. A nomogram with a well-fitted calibration curve based mostly on gene expression profiles and medical traits confirmed good discrimination based mostly on inner and exterior cohorts. These findings point out that adjustments in expression degree of metabolic genes implicated in glycolysis can contribute to reconstruction of tumor-related microenvironment.
Modifications in Methylation Patterns of Tumor Suppressor Genes throughout Prolonged Human Embryonic Stem Cell Cultures
Whereas research on embryonic stem cells have been actively carried out, little is understood in regards to the epigenetic mechanisms in human embryonic stem cells (hESCs) in prolonged tradition methods. Right here, we investigated whether or not CpG island (CGI) methylation patterns of 24 tumor suppressor genes could possibly be maintained throughout prolonged hESC cultures. In complete, 10 hESC strains have been analyzed.
For every cell line, genomic DNA was extracted from early and late passages of cell cultures. CGI methylation ranges of 24 tumor suppressor genes have been analyzed utilizing methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA), pyrosequencing, and real-time polymerase chain response (PCR). Totally different CGI methylation patterns of CASP8, FHIT, and CHFR genes have been recognized in between early and late passages in some hESC strains.
CGI methylation ranges of CASP8 considerably elevated at late passage in CHA-36, CHA-40, and CHA-42 cell strains in comparison with these at early passage. The CGI methylation of the FHIT gene was greater at late passage than at early passage in CHA-15, CHA-31, CHA-32, and iPS (FS)-1 cell strains however decreased on the late passage in CHA-20 and H1 cell strains.
Totally different CGI methylation patterns have been detected for the CHFR gene solely in iPS (FS)-1, and the extent considerably elevated at late passage. Thus, our findings present that CGI methylation patterns could possibly be altered throughout extended ESC cultures and analyzing these epigenetic adjustments is vital to evaluate the upkeep, differentiation, and medical utilization of stem cells.
A genetic danger rating utilizing human chromosomal-scale size variation can predict schizophrenia
Research point out that schizophrenia has a genetic part, nevertheless it can’t be remoted to a single gene. We aimed to find out how nicely one might predict that an individual will develop schizophrenia based mostly on their germ line genetics. We in contrast 1129 folks from the UK Biobank dataset who had a prognosis of schizophrenia to an equal variety of age matched folks drawn from the overall UK Biobank inhabitants.
For every particular person, we constructed a profile consisting of numbers. Every quantity characterised the size of segments of chromosomes. We examined a number of machine studying algorithms to find out which was simplest in predicting schizophrenia and if any enchancment in prediction happens by breaking the chromosomes into smaller chunks.
We discovered that the stacked ensemble, carried out greatest with an space beneath the receiver working attribute curve (AUC) of 0.545 (95% CI 0.539-0.550). We famous a rise within the AUC by breaking the chromosomes into smaller chunks for evaluation. Utilizing SHAP values, we recognized the X chromosome as a very powerful contributor to the predictive mannequin. We conclude that germ line chromosomal scale size variation knowledge might present an efficient genetic danger rating for schizophrenia which performs higher than probability.
Clinically important findings of high-risk mutations in human SLC29A4 gene related to diabetes mellitus kind 2 in Pakistani inhabitants
This examine carried out an in-depth evaluation combining computational and experimental verifications of the deleterious missense mutations related to the SLC29A4 protein. The purposeful annotation of the non-synonymous single nucleotide polymorphism (nsSNPs), adopted by structure-function evaluation, revealed 13 single nucleotide polymorphisms (SNP) as probably the most damaging.
Amongst these, six mutants P429T/S, L144S, M108V, N86H, and V79E, have been predicted as structurally and functionally damaging by protein stability evaluation. Additionally, these variants are situated at evolutionary conserved areas, both buried, contributing to the structural injury, or uncovered, inflicting purposeful adjustments within the protein.
These mutants have been additional taken for molecular docking research. When verified by way of experimental evaluation, the SNPs M108V (rs149798710), N86H (rs151039853), and V79E (rs17854505) confirmed an affiliation with kind 2 diabetes mellitus (T2DM). Minor allele frequency for rs149798710 (A > G) was 0.23 in controls, 0.29 in metformin responders, 0.37 in metformin non-responder, for rs151039853 (A > C) was 0.21 in controls, 0.28 in metformin responders, 0.36 in metformin non-responder and for rs17854505 (T > A) was 0.20 in controls, 0.25 in metformin responders, 0.37 in metformin non-responder.
Recombinant Human Genome polyprotein, His, Yeast-1mg |
|||
QP7370-ye-1mg | EnQuireBio | 1mg | EUR 2262 |
Recombinant Human Genome polyprotein, His, Yeast-10ug |
|||
QP7370-ye-10ug | EnQuireBio | 10ug | EUR 283.2 |
Recombinant Human Genome polyprotein, His, Yeast-50ug |
|||
QP7370-ye-50ug | EnQuireBio | 50ug | EUR 358.8 |
Recombinant Human Genome polyprotein, His, Yeast-100ug |
|||
QP7370-ye-100ug | EnQuireBio | 100ug | EUR 576 |
Recombinant Human Genome polyprotein, His, Yeast-200ug |
|||
QP7370-ye-200ug | EnQuireBio | 200ug | EUR 892.8 |
Recombinant Human Genome polyprotein, His, Yeast-500ug |
|||
QP7370-ye-500ug | EnQuireBio | 500ug | EUR 1447.2 |
Recombinant Human Genome polyprotein, His-SUMO, E.coli-1mg |
|||
QP7370-ec-1mg | EnQuireBio | 1mg | EUR 1958.4 |
Recombinant Human Genome polyprotein, His-SUMO, E.coli-10ug |
|||
QP7370-ec-10ug | EnQuireBio | 10ug | EUR 240 |
Recombinant Human Genome polyprotein, His-SUMO, E.coli-50ug |
|||
QP7370-ec-50ug | EnQuireBio | 50ug | EUR 315.6 |
Recombinant Human Genome polyprotein, His-SUMO, E.coli-100ug |
|||
QP7370-ec-100ug | EnQuireBio | 100ug | EUR 489.6 |
Recombinant Human Genome polyprotein, His-SUMO, E.coli-200ug |
|||
QP7370-ec-200ug | EnQuireBio | 200ug | EUR 760.8 |
Recombinant Human Genome polyprotein, His-SUMO, E.coli-500ug |
|||
QP7370-ec-500ug | EnQuireBio | 500ug | EUR 1272 |
Genome Polyprotein Antibody |
|||
20-abx109417 | Abbexa |
|
|
Genome polyprotein Antibody |
|||
1-CSB-PA18549A0Rb | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Dengue virus. This antibody is Unconjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody |
|||
1-CSB-PA714772LA01HYH | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human enterovirus 71. This antibody is Unconjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody |
|||
1-CSB-PA333180LA01HFD | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Hepatitis C virus genotype 1a. This antibody is Unconjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody |
|||
1-CSB-PA362073LA01HQD | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human rhinovirus A serotype 89. This antibody is Unconjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody |
|||
20-abx300967 | Abbexa |
|
|
Genome polyprotein Antibody |
|||
CSB-PA4643XA11GSV | Cusabio | 100ul / 50ul | EUR 299 |
Description: Genome polyprotein |
Genome polyprotein Antibody |
|||
CSB-PA4644XA11GSW | Cusabio | 100ul / 50ul | EUR 299 |
Description: Genome polyprotein |
Genome polyprotein Antibody (HRP) |
|||
20-abx109095 | Abbexa |
|
|
Hepatitis C Genome polyprotein |
|||
1-CSB-RP184674Ba | Cusabio |
|
|
Description: Recombinant Hepatitis C Genome polyprotein expressed in E.coli |
Genome polyprotein Antibody (HRP) |
|||
20-abx300968 | Abbexa |
|
|
Genome polyprotein Antibody (FITC) |
|||
20-abx107678 | Abbexa |
|
|
Genome polyprotein Antibody (FITC) |
|||
20-abx300969 | Abbexa |
|
|
Genome polyprotein Antibody (Biotin) |
|||
20-abx106264 | Abbexa |
|
|
Genome Polyprotein Antibody (Biotin) |
|||
20-abx105887 | Abbexa |
|
|
Genome polyprotein Antibody (Biotin) |
|||
20-abx300970 | Abbexa |
|
|
Genome Polyprotein Polyclonal Antibody |
|||
A68253 | EpiGentek |
|
|
Genome Polyprotein Polyclonal Antibody |
|||
A68254 | EpiGentek |
|
|
Genome Polyprotein Polyclonal Antibody |
|||
A56743 | EpiGentek |
|
|
Genome Polyprotein Polyclonal Antibody |
|||
A56130 | EpiGentek |
|
|
Yellow fever virus Genome polyprotein |
|||
1-CSB-EP365905YAC1 | Cusabio |
|
|
Description: Recombinant Yellow fever virus Genome polyprotein,partial expressed in E.coli |
Genome Polyprotein (HCV-Core) Antibody |
|||
33487-05111 | AssayPro | 150 ug | EUR 313.2 |
Human rhinovirus 1A Genome polyprotein |
|||
1-CSB-YP326367HQA | Cusabio |
|
|
Description: Recombinant Human rhinovirus 1A Genome polyprotein,partial expressed in Yeast |
Enterovirus 71 Genome polyprotein Antibody |
|||
20-abx109758 | Abbexa |
|
|
Genome polyprotein Antibody, HRP conjugated |
|||
1-CSB-PA18549B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Dengue virus. This antibody is HRP conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, HRP conjugated |
|||
1-CSB-PA714772LB01HYH | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human enterovirus 71. This antibody is HRP conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, HRP conjugated |
|||
1-CSB-PA333180LB01HFD | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Hepatitis C virus genotype 1a. This antibody is HRP conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, HRP conjugated |
|||
1-CSB-PA362073LB01HQD | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human rhinovirus A serotype 89. This antibody is HRP conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, FITC conjugated |
|||
1-CSB-PA18549C0Rb | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Dengue virus. This antibody is FITC conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, FITC conjugated |
|||
1-CSB-PA714772LC01HYH | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human enterovirus 71. This antibody is FITC conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, FITC conjugated |
|||
1-CSB-PA333180LC01HFD | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Hepatitis C virus genotype 1a. This antibody is FITC conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, FITC conjugated |
|||
1-CSB-PA362073LC01HQD | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human rhinovirus A serotype 89. This antibody is FITC conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, Biotin conjugated |
|||
1-CSB-PA18549D0Rb | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Dengue virus. This antibody is Biotin conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, Biotin conjugated |
|||
1-CSB-PA714772LD01HYH | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human enterovirus 71. This antibody is Biotin conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, Biotin conjugated |
|||
1-CSB-PA333180LD01HFD | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Hepatitis C virus genotype 1a. This antibody is Biotin conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, Biotin conjugated |
|||
1-CSB-PA362073LD01HQD | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human rhinovirus A serotype 89. This antibody is Biotin conjugated. Tested in the following application: ELISA |
Japanese encephalitis virus Genome polyprotein |
|||
1-CSB-EP189574Ba | Cusabio |
|
|
Description: Recombinant Japanese encephalitis virus Genome polyprotein,partial expressed in E.coli |
Enterovirus 71 Genome polyprotein Antibody (HRP) |
|||
20-abx108220 | Abbexa |
|
|
Enterovirus 71 Genome polyprotein Antibody (FITC) |
|||
20-abx106801 | Abbexa |
|
|
Enterovirus 71 Genome polyprotein Antibody (Biotin) |
|||
20-abx105382 | Abbexa |
|
|
Hepatitis C virus genotype 1a Genome polyprotein |
|||
1-CSB-EP333180HFD | Cusabio |
|
|
Description: Recombinant Hepatitis C virus genotype 1a Genome polyprotein,partial expressed in E.coli |
Hepatitis C virus genotype 1b Genome polyprotein |
|||
1-CSB-YP530838HVQ(A3) | Cusabio |
|
|
Description: Recombinant Hepatitis C virus genotype 1b Genome polyprotein,partial expressed in Yeast |
Hepatitis C virus genotype 1b Genome polyprotein |
|||
1-CSB-YP530838HVQ(A4) | Cusabio |
|
|
Description: Recombinant Hepatitis C virus genotype 1b Genome polyprotein,partial expressed in Yeast |
Hepatitis C virus genotype 1a Genome polyprotein |
|||
1-CSB-MP333180HFD | Cusabio |
|
|
Description: Recombinant Hepatitis C virus genotype 1a Genome polyprotein,partial expressed in Mammalian cell |
Genome Polyprotein Polyclonal Antibody, HRP Conjugated |
|||
A68252 | EpiGentek |
|
|
Genome Polyprotein Polyclonal Antibody, HRP Conjugated |
|||
A68255 | EpiGentek |
|
|
Genome Polyprotein Polyclonal Antibody, HRP Conjugated |
|||
A56744 | EpiGentek |
|
|
Genome Polyprotein Polyclonal Antibody, HRP Conjugated |
|||
A56131 | EpiGentek |
|
|
Human rhinovirus A serotype 89 Genome polyprotein |
|||
1-CSB-EP362073HQD | Cusabio |
|
|
Description: Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial expressed in E.coli |
Human rhinovirus A serotype 89 Genome polyprotein |
|||
1-CSB-EP362073HQDb0 | Cusabio |
|
|
Description: Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial expressed in E.coli |
Human rhinovirus A serotype 89 Genome polyprotein |
|||
1-CSB-YP362073HQD | Cusabio |
|
|
Description: Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial expressed in Yeast |
Genome Polyprotein Polyclonal Antibody, FITC Conjugated |
|||
A68251 | EpiGentek |
|
|
Genome Polyprotein Polyclonal Antibody, FITC Conjugated |
|||
A68256 | EpiGentek |
|
|
Genome Polyprotein Polyclonal Antibody, FITC Conjugated |
|||
A56745 | EpiGentek |
|
|
Genome Polyprotein Polyclonal Antibody, FITC Conjugated |
|||
A56132 | EpiGentek |
|
|
Genome Polyprotein Polyclonal Antibody, Biotin Conjugated |
|||
A68250 | EpiGentek |
|
|
Genome Polyprotein Polyclonal Antibody, Biotin Conjugated |
|||
A68257 | EpiGentek |
|
|
Genome Polyprotein Polyclonal Antibody, Biotin Conjugated |
|||
A56746 | EpiGentek |
|
|
Genome Polyprotein Polyclonal Antibody, Biotin Conjugated |
|||
A56133 | EpiGentek |
|
|
Rhinovirus A serotype 89 Genome polyprotein Antibody |
|||
20-abx109372 | Abbexa |
|
|
Genome Polyprotein (HCV-Core) Antibody (Biotin Conjugate) |
|||
33487-05121 | AssayPro | 150 ug | EUR 442.8 |
Rhinovirus A serotype 89 Genome polyprotein Antibody (HRP) |
|||
20-abx108723 | Abbexa |
|
|
Rhinovirus A serotype 89 Genome polyprotein Antibody (FITC) |
|||
20-abx107303 | Abbexa |
|
|
Genome Polyprotein (HCV-Core) AssayLite Antibody (RPE Conjugate) |
|||
33487-05151 | AssayPro | 150 ug | EUR 513.6 |
Genome Polyprotein (HCV-Core) AssayLite Antibody (APC Conjugate) |
|||
33487-05161 | AssayPro | 150 ug | EUR 513.6 |
Genome Polyprotein (HCV-Core) AssayLite Antibody (FITC Conjugate) |
|||
33487-05141 | AssayPro | 150 ug | EUR 513.6 |
Genome Polyprotein (HCV-Core) AssayLite Antibody (PerCP Conjugate) |
|||
33487-05171 | AssayPro | 150 ug | EUR 565.2 |
Recombinant MAYV Structural polyprotein Protein |
|||
VAng-Wyb3702-inquire | Creative Biolabs | inquire | Ask for price |
Description: Mayaro virus (strain Brazil) Structural polyprotein, recombinant protein. |
Recombinant MAYV NS polyprotein Protein (aa 1005-1327) |
|||
VAng-Wyb3703-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5586 |
Description: Mayaro virus (strain Brazil) Non-structural polyprotein, recombinant protein. |
Recombinant MAYV NS polyprotein Protein (aa 1005-1327) |
|||
VAng-Wyb3703-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3640.8 |
Description: Mayaro virus (strain Brazil) Non-structural polyprotein, recombinant protein. |
Recombinant JEV Polyprotein NS5 (aa 2780-3428) Protein |
|||
VAng-Wyb3462-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 687.6 |
Description: Japanese encephalitis virus Polyprotein NS5 protein, recombinant protein. |
Recombinant JEV Polyprotein NS5 (aa 2780-3428) Protein |
|||
VAng-Wyb3462-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3952.8 |
Description: Japanese encephalitis virus Polyprotein NS5 protein, recombinant protein. |
Recombinant JEV Polyprotein NS5 (aa 2780-3428) Protein |
|||
VAng-Wyb3462-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2535.6 |
Description: Japanese encephalitis virus Polyprotein NS5 protein, recombinant protein. |
Recombinant JEV Polyprotein NS5 (aa 2780-3428) [His] Protein |
|||
VAng-Wyb3463-1mg | Creative Biolabs | 1 mg | EUR 5982 |
Description: Japanese encephalitis virus Polyprotein NS5 protein, recombinant protein. |
Recombinant JEV Polyprotein NS5 (aa 2780-3428) [His] Protein |
|||
VAng-Wyb3463-500g | Creative Biolabs | 500 µg | EUR 3837.6 |
Description: Japanese encephalitis virus Polyprotein NS5 protein, recombinant protein. |
Recombinant JEV Polyprotein NS5 (aa 2780-3428) [His] Protein |
|||
VAng-Wyb3463-50g | Creative Biolabs | 50 µg | EUR 1215.6 |
Description: Japanese encephalitis virus Polyprotein NS5 protein, recombinant protein. |
Recombinant MAYV Structural polyprotein Protein (aa 807-1242) |
|||
VAng-Wyb3704-100g | Creative Biolabs | 100 µg | EUR 8276.4 |
Description: Mayaro virus (strain Brazil) Structural polyprotein, recombinant protein. |
Recombinant MAYV Structural polyprotein Protein (aa 807-1242) |
|||
VAng-Wyb3704-10g | Creative Biolabs | 10 µg | EUR 3606 |
Description: Mayaro virus (strain Brazil) Structural polyprotein, recombinant protein. |
Recombinant MAYV Structural polyprotein Protein (aa 807-1242) |
|||
VAng-Wyb3704-50g | Creative Biolabs | 50 µg | EUR 5272.8 |
Description: Mayaro virus (strain Brazil) Structural polyprotein, recombinant protein. |
Recombinant CHIKV Structural Polyprotein |
|||
VAng-Lsx0030-inquire | Creative Biolabs | inquire | Ask for price |
Description: CHIKV Structural Polyprotein, recombinant protein from E. coli. |
Recombinant MMTV Gag Polyprotein (aa 2-99) [His] |
|||
VAng-Lsx0591-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3612 |
Description: Mouse Mammary Tumor Virus Gag Polyprotein (aa 2-99) [His], recombinant protein from E. coli. |
Recombinant MMTV Gag Polyprotein (aa 2-99) [His] |
|||
VAng-Lsx0591-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2446.8 |
Description: Mouse Mammary Tumor Virus Gag Polyprotein (aa 2-99) [His], recombinant protein from E. coli. |
Recombinant MMTV Gag Polyprotein (aa 2-99) [His] |
|||
VAng-Lsx0591-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1675.2 |
Description: Mouse Mammary Tumor Virus Gag Polyprotein (aa 2-99) [His], recombinant protein from E. coli. |
Recombinant MLV Radiation Pol Polyprotein |
|||
VAng-Lsx0414-inquire | Creative Biolabs | inquire | Ask for price |
Description: MLV Radiation Pol Polyprotein, recombinant protein from E. coli. |
Recombinant CHIKV Non-structural Polyprotein |
|||
VAng-Lsx0031-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5001.6 |
Description: CHIKV Non-structural Polyprotein, recombinant protein from E. coli. |
Recombinant CHIKV Non-structural Polyprotein |
|||
VAng-Lsx0031-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3345.6 |
Description: CHIKV Non-structural Polyprotein, recombinant protein from E. coli. |
Recombinant hepatitis Non-structural polyprotein pORF1 Protein, His, E.coli-10ug |
|||
QP7125-10ug | EnQuireBio | 10ug | EUR 426 |
Recombinant hepatitis Non-structural polyprotein pORF1 Protein, His, E.coli-1mg |
|||
QP7125-1mg | EnQuireBio | 1mg | EUR 3037.2 |
Recombinant hepatitis Non-structural polyprotein pORF1 Protein, His, E.coli-50ug |
|||
QP7125-50ug | EnQuireBio | 50ug | EUR 567.6 |
Recombinant HTLV-2 gp 2 Gag-Pro-Pol Polyprotein |
|||
VAng-Lsx0325-inquire | Creative Biolabs | inquire | Ask for price |
Description: HTLV-2 gp 2 Gag-Pro-Pol Polyprotein, recombinant protein from E. coli. |
Recombinant hepatitis Non-structural polyprotein pORF1 Protein, His, E.coli-100ug |
|||
QP7125-100ug | EnQuireBio | 100ug | EUR 925.2 |
Recombinant hepatitis Non-structural polyprotein pORF1 Protein, His, E.coli-200ug |
|||
QP7125-200ug | EnQuireBio | 200ug | EUR 1468.8 |
Recombinant hepatitis Non-structural polyprotein pORF1 Protein, His, E.coli-500ug |
|||
QP7125-500ug | EnQuireBio | 500ug | EUR 1936.8 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) polyprotein, His, Yeast-1mg |
|||
QP9739-ye-1mg | EnQuireBio | 1mg | EUR 3296.4 |
Recombinant Hepatitis C Virus polyprotein, His, E.coli-1mg |
|||
QP8939-ec-1mg | EnQuireBio | 1mg | EUR 2763.6 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) polyprotein, His, Yeast-100ug |
|||
QP9739-ye-100ug | EnQuireBio | 100ug | EUR 945.6 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) polyprotein, His, Yeast-10ug |
|||
QP9739-ye-10ug | EnQuireBio | 10ug | EUR 434.4 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) polyprotein, His, Yeast-200ug |
|||
QP9739-ye-200ug | EnQuireBio | 200ug | EUR 1512 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) polyprotein, His, Yeast-500ug |
|||
QP9739-ye-500ug | EnQuireBio | 500ug | EUR 2164.8 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) polyprotein, His, Yeast-50ug |
|||
QP9739-ye-50ug | EnQuireBio | 50ug | EUR 576 |
Recombinant Hepatitis C Virus polyprotein, His, E.coli-10ug |
|||
QP8939-ec-10ug | EnQuireBio | 10ug | EUR 391.2 |
Recombinant Hepatitis C Virus polyprotein, His, E.coli-50ug |
|||
QP8939-ec-50ug | EnQuireBio | 50ug | EUR 522 |
Recombinant Hepatitis C Virus polyprotein, His, E.coli-100ug |
|||
QP8939-ec-100ug | EnQuireBio | 100ug | EUR 848.4 |
Recombinant Hepatitis C Virus polyprotein, His, E.coli-200ug |
|||
QP8939-ec-200ug | EnQuireBio | 200ug | EUR 1338 |
Recombinant Hepatitis C Virus polyprotein, His, E.coli-500ug |
|||
QP8939-ec-500ug | EnQuireBio | 500ug | EUR 1816.8 |
Recombinant Hepatitis C virus genotype 1a (isolate 1) polyprotein, His-SUMO, Mammal-1mg |
|||
QP6996-1mg | EnQuireBio | 1mg | EUR 3037.2 |
Recombinant Hepatitis C virus genotype 1a (isolate 1) polyprotein, His-SUMO, Mammal-10ug |
|||
QP6996-10ug | EnQuireBio | 10ug | EUR 426 |
Recombinant Hepatitis C virus genotype 1a (isolate 1) polyprotein, His-SUMO, Mammal-200ug |
|||
QP6996-200ug | EnQuireBio | 200ug | EUR 1468.8 |
Recombinant Hepatitis C virus genotype 1a (isolate 1) polyprotein, His-SUMO, Mammal-20ug |
|||
QP6996-20ug | EnQuireBio | 20ug | EUR 523.2 |
Recombinant Hepatitis C virus genotype 1a (isolate 1) polyprotein, His-SUMO, Mammal-500ug |
|||
QP6996-500ug | EnQuireBio | 500ug | EUR 1936.8 |
HCV NS3 recombinant antigen a.a 1400 to a.a 1643 of HCV polyprotein 22 kDa |
|||
00117-V-100ugvial | Virogen | 100 ug/vial | EUR 150 |
Description: HCV NS3 recombinant antigen a.a 1400 to a.a 1643 of HCV polyprotein 22 kDa |
HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa |
|||
00115-V-100ugvial | Virogen | 100 ug/vial | EUR 150 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa |
HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. |
|||
00116-V-100ugvial | Virogen | 100 ug/vial | EUR 150 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. |
HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Biotin conjugate. |
|||
00115-V-B-100ugvial | Virogen | 100 ug/vial | EUR 150 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Biotin conjugate. |
HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa . Rhodamine conjugate. |
|||
00115-V-R-100ugvial | Virogen | 100 ug/vial | EUR 150 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa . Rhodamine conjugate. |
HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Biotin conjugate. |
|||
00116-V-B-100ugvial | Virogen | 100 ug/vial | EUR 150 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Biotin conjugate. |
HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Fluorescein conjugate. |
|||
00115-V-F-100ugvial | Virogen | 100 ug/vial | EUR 150 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Fluorescein conjugate. |
HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Rhodamine conjugate. |
|||
00116-V-R-100ugvial | Virogen | 100 ug/vial | EUR 150 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Rhodamine conjugate. |
HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Fluorescein conjugate. |
|||
00116-V-F-100ugvial | Virogen | 100 ug/vial | EUR 150 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Fluorescein conjugate. |
HIV-1 gag Polyprotein (121-140) |
|||
H-4776.0500 | Bachem | 0.5mg | EUR 849.6 |
Description: Sum Formula: C86H138N26O34; CAS# [1815618-20-2] |
HIV-1 gag Polyprotein (121-140) |
|||
H-4776.1000 | Bachem | 1.0mg | EUR 1488 |
Description: Sum Formula: C86H138N26O34; CAS# [1815618-20-2] |
Polyprotein P1234 Antibody |
|||
CSB-PA329710XA31VAZ | Cusabio | 100ul / 50ul | EUR 299 |
Description: Non-structural polyprotein (Polyprotein nsP1234) (P1234) [Cleaved into: P123, P123', mRNA-capping enzyme nsP1 (EC 2.1.1.-) (EC 2.7.7.-) (Non-structural protein 1), Protease nsP2 (EC 3.1.3.33) (EC 3.4.22.-) (EC 3.6.1.15) (EC 3.6.4.13) (Non-structural protein 2) (nsP2), Non-structural protein 3 (nsP3), Non-structural protein 3' (nsP3'), RNA-directed RNA polymerase nsP4 (EC 2.7.7.48) (Non-structural protein 4) (nsP4)] |
Gag Polyprotein (gag) Antibody |
|||
20-abx317799 | Abbexa |
|
|
Gag Polyprotein (gag) Antibody |
|||
20-abx318946 | Abbexa |
|
|
Gag Polyprotein (GAG) Antibody |
|||
abx331332-100ul | Abbexa | 100 ul | EUR 510 |
Turnip mosaic virus Polyprotein |
|||
1-CSB-EP2708TJM | Cusabio |
|
|
Description: Recombinant Turnip mosaic virus Polyprotein,partial expressed in E.coli |
Gag Polyprotein (GAG) Antibody (HRP) |
|||
20-abx317800 | Abbexa |
|
|
Gag Polyprotein (GAG) Antibody (HRP) |
|||
20-abx318947 | Abbexa |
|
|
Gag Polyprotein (GAG) Antibody (FITC) |
|||
20-abx317801 | Abbexa |
|
|
Gag Polyprotein (GAG) Antibody (FITC) |
|||
20-abx318948 | Abbexa |
|
|
Gag Polyprotein (GAG) Antibody (FITC) |
|||
20-abx107749 | Abbexa |
|
|
Structural Polyprotein (VP2) Antibody |
|||
abx224337-100ug | Abbexa | 100 ug | EUR 493.2 |
Sindbis virus Structural polyprotein |
|||
1-CSB-CF361018SHZ | Cusabio |
|
|
Description: Recombinant Sindbis virus Structural polyprotein,partial expressed in in vitro E.coli expression system |
Sindbis virus Structural polyprotein |
|||
1-CSB-CF361018SHZb2 | Cusabio |
|
|
Description: Recombinant Sindbis virus Structural polyprotein,partial expressed in in vitro E.coli expression system |
Gag Polyprotein (GAG) Antibody (Biotin) |
|||
20-abx317802 | Abbexa |
|
|
Gag Polyprotein (GAG) Antibody (Biotin) |
|||
20-abx318949 | Abbexa |
|
|
Gag Polyprotein (GAG) Antibody (Biotin) |
|||
20-abx106336 | Abbexa |
|
|
Hepatitis E virus genotype 1 Non-structural polyprotein pORF1 (ORF1) |
|||
1-CSB-EP327230HGE | Cusabio |
|
|
Description: Recombinant Hepatitis E virus genotype 1 Non-structural polyprotein pORF1(ORF1),partial expressed in E.coli |
HIV-1 Gag-Pol polyprotein Antibody (HRP) |
|||
20-abx109153 | Abbexa |
|
|
HIV-1 Gag-Pol polyprotein Antibody (FITC) |
|||
20-abx107735 | Abbexa |
|
|
HIV-1 Gag-Pol polyprotein Antibody (Biotin) |
|||
20-abx106322 | Abbexa |
|
|
Non-Structural Polyprotein Porf1 (ORF1) Antibody |
|||
20-abx300971 | Abbexa |
|
|
HIV-1 Gag-Pol Polyprotein (gag-pol) Antibody |
|||
20-abx110593 | Abbexa |
|
|
Moloney murine leukemia virus Gag polyprotein (gag) |
|||
1-CSB-EP356017MHK | Cusabio |
|
|
Description: Recombinant Moloney murine leukemia virus Gag polyprotein(gag) ,partial expressed in E.coli |
Moloney murine leukemia virus Gag polyprotein (gag) |
|||
1-CSB-EP356017MHKe0 | Cusabio |
|
|
Description: Recombinant Moloney murine leukemia virus Gag polyprotein(gag),partial expressed in E.coli |
Moloney murine leukemia virus Gag polyprotein Antibody |
|||
20-abx110606 | Abbexa |
|
|
Pre-Glycoprotein Polyprotein GP Complex (GPC) Antibody |
|||
20-abx319921 | Abbexa |
|
|
Human HERV- K_7p22.1 provirus ancestral Gag polyprotein, ERVK6 E |
|||
ELI-27186h | Lifescience Market | 96 Tests | EUR 988.8 |
Human HERV- K_3q12.3 provirus ancestral Env polyprotein, ERVK5 E |
|||
ELI-09980h | Lifescience Market | 96 Tests | EUR 988.8 |
Human HERV-K_7p22.1 provirus ancestral Env polyprotein (ERVK-6) |
|||
1-CSB-EP724336HUa0 | Cusabio |
|
|
Description: Recombinant Human HERV-K_7p22.1 provirus ancestral Env polyprotein(ERVK-6),partial expressed in E.coli |
Lassa virus Pre-glycoprotein polyprotein GP complex (GPC) |
|||
1-CSB-EP362480LNP2 | Cusabio |
|
|
Description: Recombinant Lassa virus Pre-glycoprotein polyprotein GP complex(GPC),partial expressed in E.coli |
Moloney murine leukemia virus Gag polyprotein Antibody (HRP) |
|||
20-abx109167 | Abbexa |
|
|
Pre-Glycoprotein Polyprotein GP Complex (GPC) Antibody (HRP) |
|||
20-abx319922 | Abbexa |
|
|
Pre-Glycoprotein Polyprotein GP Complex (GPC) Antibody (FITC) |
|||
20-abx319923 | Abbexa |
|
|
×
Therefore, this examine concludes that SLC29A4 M108V (rs149798710), N86H (rs151039853), and V79E (rs17854505) polymorphisms have been related to the elevated danger of T2DM in addition to with the elevated danger in direction of the failure of metformin therapeutic response in T2DM sufferers of Pakistan. Communicated by Ramaswamy H. Sarma.
Tags: acetylated lysine antibody ago2 antibody amotl2 antibody anti np antibody bca protein assay kit bradford protein assay caspase 3 staining cell lysis buffer complete protease inhibitor cocktail culture vessel cxcr2 antibody dna quantification kit elisa plate reader elisa reader exosap it protocol fitc labeling genomic dna isolation kits human serum luria broth mesenchymal stem cell media mouse embryonic fibroblasts cell culture pbs buffer plasmid midi prep protein extraction kit qpcr sybr green rhoc antibody semidry transfer buffer streptavidin size sulfo nhs lc biotin western blotting apparatus zo-1 antibody